The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
ADMET in silico modelling: towards prediction paradise?
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420
Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
Handbook of Molecular Descriptors
Todeschini, R., & Consonni, V. (2000) · Methods and Principles in Medicinal Chemistry · doi:10.1002/9783527613106 · Cited by 4,107 · cited 1×
“A wide variety of descriptors for use in QSAR studies have been developed over the last 40 year”
MethodDrug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734
Ertl, P., Rohde, B., & Selzer, P. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000942e · Cited by 3,084
Prediction of drug solubility from structure
Jorgensen, W. L., & Duffy, E. M. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00008-x · Cited by 891
The Practice of Medicinal Chemistry
(2003) · Elsevier eBooks · doi:10.1016/b978-0-12-744481-9.x5000-4 · Cited by 702
Pharmacophore perception, development, and use in drug design
Güner, O. F. (2000) · Medical Entomology and Zoology · Cited by 689
Predicting the Impact of Physiological and Biochemical Processes on Oral Drug Bioavailability
Agoram, B., Woltosz, W. S., & Bolger, M. B. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00179-x · Cited by 651
Clark, D. E. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js9804011 · Cited by 627
Property-Based Design: Optimization of Drug Absorption and Pharmacokinetics
van de Waterbeemd, H., Smith, D. A., Beaumont, K., & Walker, D. K. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm000407e · Cited by 599
Self-citationvan de Waterbeemd, H., Camenisch, G., Folkers, G., Chretien, J. R., & Raevsky, O. A. (1998) · Journal of Drug Targeting · doi:10.3109/10611869808997889 · Cited by 587
Self-citationMolecular fields in quantitative structure–permeation relationships: the VolSurf approach
Cruciani, G., Crivori, P., Carrupt, P.-A., & Testa, B. (2000) · Journal of Molecular Structure: THEOCHEM · doi:10.1016/s0166-1280(99)00360-7 · Cited by 566
Predicting plasma protein binding of drugs: a new approach
Kratochwil, N. A., Huber, W., Müller, F., Kansy, M., & Gerber, P. R. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01074-2 · Cited by 553
A general pattern for substrate recognition by P‐glycoprotein
Seelig, A. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2510252.x · Cited by 527
Zhao, Y. H., Le, J., Abraham, M. H., Hersey, A., Eddershaw, P. J., Luscombe, C. N., Boutina, D., Beck, G., Sherborne, B., Cooper, I., et al. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1031 · Cited by 526
Managing the drug discovery/development interface
Kennedy, T. (1997) · Drug Discovery Today · doi:10.1016/s1359-6446(97)01099-4 · Cited by 522
Clark, D. E. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js980402t · Cited by 519
Willson, T. M., & Kliewer, S. A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd753 · Cited by 503
Predicting Blood−Brain Barrier Permeation from Three-Dimensional Molecular Structure
Crivori, P., Cruciani, G., Carrupt, P.-A., & Testa, B. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990968+ · Cited by 430
Poulin, P., & Theil, F. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/(sici)1520-6017(200001)89:1<16::aid-jps3>3.0.co;2-e · Cited by 424
Role of transport proteins in drug absorption, distribution and excretion
Ayrton, A., & Morgan, P. (2001) · Xenobiotica · doi:10.1080/00498250110060969 · Cited by 421
Lipophilicity in Drug Action and Toxicology
(1996) · Methods and Principles in Medicinal Chemistry · doi:10.1002/9783527614998 · Cited by 409
A Scoring Scheme for Discriminating between Drugs and Nondrugs
Sadowski, J., & Kubinyi, H. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9706776 · Cited by 392
Cavalli, A., Poluzzi, E., De Ponti, F., & Recanatini, M. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0208875 · Cited by 382
Bevan, C. D., & Lloyd, R. S. (2000) · Analytical Chemistry · doi:10.1021/ac9912247 · Cited by 345
QSAR Model for Drug Human Oral Bioavailability
Yoshida, F., & Topliss, J. G. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm0000564 · Cited by 299
Unmasking the Dynamic Interplay between Intestinal P-Glycoprotein and CYP3A4
Cummins, C. L., Jacobsen, W., & Benet, L. Z. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.1036 · Cited by 289
Gumbleton, M., & Audus, K. L. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1119 · Cited by 286
A Rigorous Test for SPARC's Chemical Reactivity Models: Estimation of More Than 4300 Ionization pKas
Hilal, S. H., Karickhoff, S. W., & Carreira, L. A. (1995) · Quantitative Structure-Activity Relationships · doi:10.1002/qsar.19950140405 · Cited by 283
Structure–activity relationship of P-glycoprotein substrates and modifiers
Seelig, A., & Landwojtowicz, E. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00177-9 · Cited by 275
Progress in predicting human ADME parameters in silico
Ekins, S., Waller, C. L., Swaan, P. W., Cruciani, G., Wrighton, S. A., & Wikel, J. H. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00109-x · Cited by 274
Cheminformatic Models To Predict Binding Affinities to Human Serum Albumin
Colmenarejo, G., Alvarez-Pedraglio, A., & Lavandera, J.-L. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010960b · Cited by 254
Experimental and Computational Screening Models for the Prediction of Intestinal Drug Absorption
Stenberg, P., Norinder, U., Luthman, K., & Artursson, P. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm001101a · Cited by 252
Lipophilicity in PK design: methyl, ethyl, futile
van de Waterbeemd, H., Smith, D. A., & Jones, B. C. (2001) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1008192010023 · Cited by 244
Self-citationde Lange, E. C. M., & Danhof, M. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241100-00001 · Cited by 244
The emerging importance of predictive ADME simulation in drug discovery
Selick, H. E., Beresford, A. P., & Tarbit, M. H. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(01)02100-6 · Cited by 233
Lombardo, F., Obach, R. S., Shalaeva, M. Y., & Gao, F. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0200409 · Cited by 213
Prediction of adipose tissue: Plasma partition coefficients for structurally unrelated drugs
Poulin, P., Schoenlein, K., & Theil, F. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200104)90:4<436::aid-jps1002>3.0.co;2-p · Cited by 213
Ekins, S., de Groot, M. J., & Jones, J. P. (2001) · PubMed · Cited by 201
Experimental and Computational Screening Models for Prediction of Aqueous Drug Solubility
Bergström, C. A. S., Norinder, U., Luthman, K., & Artursson, P. (2002) · Pharmaceutical Research · doi:10.1023/a:1014224900524 · Cited by 196
A Computational Ensemble Pharmacophore Model for Identifying Substrates of P-Glycoprotein
Penzotti, J. E., Lamb, M. L., Evensen, E., & Grootenhuis, P. D. J. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0255062 · Cited by 177
Prediction of intestinal absorption: comparative assessment of gastroplus™ and idea™
Parrott, N., & Lavé, T. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00132-x · Cited by 170
Modeling Blood-Brain Barrier Partitioning Using the Electrotopological State
Rose, K., Hall, L. H., & Kier, L. B. (2002) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci010127n · Cited by 170
Three-Dimensional Quantitative Structure-Activity Relationships of Inhibitors of P-Glycoprotein
Ekins, S., Kim, R. B., Leake, B. F., Dantzig, A. H., Schuetz, E. G., Lan, L.-B., Yasuda, K., Shepard, R. L., Winter, M. A., Schuetz, J. D., et al. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.5.964 · Cited by 166
Goh, L.-B., Spears, K. J., Yao, D., Ayrton, A., Morgan, P., Wolf, C. R., & Friedberg, T. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01355-2 · Cited by 157
Seelig, A., Li‐Blatter, X., & Wohnsland, F. (2000) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp38111 · Cited by 148
Discriminating between Drugs and Nondrugs by Prediction of Activity Spectra for Substances (PASS)
Anzali, S., Barnickel, G., Cezanne, B., Krug, M., Filimonov, D. A., & Poroikov, V. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0010670 · Cited by 146
Mandagere, A. K., Thompson, T. N., & Hwang, K. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010152k · Cited by 143
Andrews, C. W., Bennett, L., & Yu, L. X. (2000) · Pharmaceutical Research · doi:10.1023/a:1007556711109 · Cited by 139
Computer systems for the prediction of xenobiotic metabolism
Langowski, J., & Long, A. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00011-x · Cited by 138
The Functional Role of P-Glycoprotein in the Blood–Brain Barrier
van Asperen, J., Mayer, U., van Tellingen, O., & Beijnen, J. H. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js9701364 · Cited by 138
Kulkarni, A., Han, Y., & Hopfinger, A. J. (2002) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci010108d · Cited by 116
Pharmacokinetics and Metabolism in Drug Design
Smith, D. A., Waterbeemd, H. V. D. 1., & Walker, D. K. (2003) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(03)00124-7 · Cited by 112
Rational approaches to drug design
(2001) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(01)01309-5 · Cited by 112
The absolute oral bioavailability of selected drugs.
Sietsema, W. K. (1989) · PubMed · Cited by 109
Development of predictive pharmacokinetic simulation models for drug discovery
Norris, D. A., Leesman, G. D., Sinko, P. J., & Grass, G. M. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00232-1 · Cited by 108
A simple model for the prediction of blood–brain partitioning
Fehér, M., Sourial, E., & Schmidt, J. M. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00422-1 · Cited by 104
Ekins, S., Bravi, G., Binkley, S. N., Gillespie, J. S., Ring, B. J., Wikel, J. H., & Wrighton, S. A. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15175-6 · Cited by 101
Pugh, W. J., Değim, İ. T., & Hadgraft, J. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00326-4 · Cited by 99
AI and SAR approaches for predicting chemical carcinogenicity: Survey and status report
Richard, A. M., & Benigni, R. (2002) · SAR and QSAR in environmental research · doi:10.1080/10629360290002055 · Cited by 80
A simple model to predict blood–brain barrier permeation from 3D molecular fields
Ooms, F., Weber, P. B., Carrupt, P., & Testa, B. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00074-1 · Cited by 77
Modeling of active transport systems
Zhang, E. Y., Phelps, M. A., Chang, C. K., Ekins, S., & Swaan, P. W. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00007-8 · Cited by 76
Schneider, G., Coassolo, P., & Lavé, T. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm991030j · Cited by 74
Application of in silico approaches to predicting drug–drug interactions
Ekins, S., & Wrighton, S. A. (2001) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(01)00119-8 · Cited by 73
Saiakhov, R., Stefan, L. R., & Klopman, G. (2000) · Perspectives in Drug Discovery and Design · doi:10.1023/a:1008723723679 · Cited by 67
Molecular and Pharmacokinetic Properties of 222 Commercially Available Oral Drugs in Humans.
Sakaeda, T., Okamura, N., Nagata, S., Yagami, T., Horinouchi, M., Okumura, K., Yamashita, F., & Hashida, M. (2001) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.24.935 · Cited by 67
High-throughput and in silico techniques in drug metabolism and pharmacokinetics.
van de Waterbeemd, H. (2002) · PubMed · Cited by 66
The Use of In Vitro Methods to Predict In Vivo Pharmacokinetics and Drug Interactions
Bachmann, K. A., & Ghosh, R. (2001) · Current Drug Metabolism · doi:10.2174/1389200013338504 · Cited by 65
Raevsky, O. A., Trepalin, S. V., Trepalina, H. P., Gerasimenko, V. A., & Raevskaja, O. E. (2002) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci010097o · Cited by 59
Prediction of blood-brain partitioning using Monte Carlo simulations of molecules in water
Kaznessis, Y. N., Snow, M. E., & Blankley, C. J. (2001) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1012240703377 · Cited by 50
Rodrigues, A. D., Winchell, G. A., & Dobrinska, M. R. (2001) · The Journal of Clinical Pharmacology · doi:10.1177/00912700122010212 · Cited by 45
der Graaf, P. H. V., Nilsson, J. E., van Schaick, E. A., & Danhof, M. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js980294a · Cited by 39
Evolutionary computational methods to predict oral bioavailability QSPRs.
Bains, W., Gilbert, R., Sviridenko, L., Gascon, J.-M., Scoffin, R. A., Birchall, K., Harvey, I. R., & Caldwell, J. (2002) · PubMed · Cited by 29
Can the Internet help to meet the challenges in ADME and e-ADME?
Waterbeemd, H. V. D., & de Groot, M. J. (2002) · SAR and QSAR in environmental research · doi:10.1080/10629360290014269 · Cited by 13
Predicting Oral Drug Absorption in Humans
Amidon, G., Yu, L., & Gatlin, L. (1999) · CRC Press eBooks · doi:10.1201/9780203909478-13 · Cited by 11
MS, Parkinson's disease and physiotherapy
(2002) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2002.40538 · Cited by 3
Cited by
Docking and scoring in virtual screening for drug discovery: methods and applications
Kitchen, D. B., Decornez, H., Furr, J. R., & Bajorath, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1549 · Cited by 4,150
The influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403
admetSAR: A Comprehensive Source and Free Tool for Assessment of Chemical ADMET Properties
Cheng, F., Li, W., Zhou, Y., Shen, J., Wu, Z., Liu, G., Lee, P. W., & Tang, Y. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci300367a · Cited by 2,222
Designing antimicrobial peptides: form follows function
Fjell, C. D., Hiss, J. A., Hancock, R. E. W., & Schneider, G. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3591 · Cited by 2,035
Martin, Y. C. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0492002 · Cited by 1,020
Metadata
- Authors
- van de Waterbeemd, H., & Gifford, E.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2003-03
- Volume
- 2
- Issue
- 3
- Pages
- 192-204
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W3175318380
- Cited by
- 1,863
- References
- 79
- FWCI
- 3.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.